Lu Z, Berson J F, Chen Y, Turner J D, Zhang T, Sharron M, Jenks M H, Wang Z, Kim J, Rucker J, Hoxie J A, Peiper S C, Doms R W
James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6426-31. doi: 10.1073/pnas.94.12.6426.
The chemokine receptor CXCR4 functions as a fusion coreceptor for T cell tropic and dual-tropic HIV-1 strains. To identify regions of CXCR4 that are important for coreceptor function, CXCR4-CXCR2 receptor chimeras were tested for the ability to support HIV-1 envelope (env) protein-mediated membrane fusion. Receptor chimeras containing the first and second extracellular loops of CXCR4 supported fusion by T tropic and dual-tropic HIV-1 and HIV-2 strains and binding of a monoclonal antibody to CXCR4, 12G5, that blocks CXCR4-dependent infection by some virus strains. The second extracellular loop of CXCR4 was sufficient to confer coreceptor function to CXCR2 for most virus strains tested but did not support binding of 12G5. Truncation of the CXCR4 cytoplasmic tail or mutation of a conserved DRY motif in the second intracellular loop did not affect coreceptor function, indicating that phosphorylation of the cytoplasmic tail and the DRY motif are not required for coreceptor function. The results implicate the involvement of multiple CXCR4 domains in HIV-1 coreceptor function, especially the second extracellular loop, though the structural requirements for coreceptor function were somewhat variable for different env proteins. Finally, a hybrid receptor in which the amino terminus of CXCR4 was replaced by that of CCR5 was active as a coreceptor for M tropic, T tropic, and dual-tropic env proteins. We propose that dual tropism may evolve in CCR5-restricted HIV-1 strains through acquisition of the ability to utilize the first and second extracellular loops of CXCR4 while retaining the ability to interact with the CCR5 amino-terminal domain.
趋化因子受体CXCR4作为T细胞嗜性和双嗜性HIV-1毒株的融合共受体发挥作用。为了确定CXCR4中对共受体功能重要的区域,对CXCR4-CXCR2受体嵌合体支持HIV-1包膜(env)蛋白介导的膜融合的能力进行了测试。含有CXCR4第一和第二细胞外环的受体嵌合体支持T嗜性和双嗜性HIV-1及HIV-2毒株的融合,以及一种可阻断某些病毒株依赖CXCR4感染的抗CXCR4单克隆抗体12G5的结合。对于大多数测试的病毒株,CXCR4的第二细胞外环足以赋予CXCR2共受体功能,但不支持12G5的结合。CXCR4胞质尾的截短或第二细胞内环中保守的DRY基序的突变不影响共受体功能,这表明胞质尾的磷酸化和DRY基序对于共受体功能并非必需。结果表明多个CXCR4结构域参与了HIV-1共受体功能,尤其是第二细胞外环,尽管不同env蛋白对共受体功能的结构要求存在一定差异。最后,一种将CXCR4氨基末端替换为CCR5氨基末端的杂合受体作为M嗜性、T嗜性和双嗜性env蛋白的共受体具有活性。我们提出,在CCR5限制型HIV-1毒株中,双嗜性可能通过获得利用CXCR4第一和第二细胞外环的能力同时保留与CCR5氨基末端结构域相互作用的能力而进化而来。